Del. Court Won't Pause 'Orange Book' Delisting
By Matthew Perlman · December 5, 2022, 8:38 PM EST
A Delaware federal court on Monday refused to pause an order requiring Jazz Pharmaceuticals to remove a patent for a narcolepsy drug from health regulators' listing of approved drugs, but the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login